129 related articles for article (PubMed ID: 31529159)
1. How adverse events and permanent medication stoppages affect changes in patients' beliefs about oral antineoplastic agents.
Marshall VK; Given CW; Sikorskii A; Given BA; Lehto RH
Support Care Cancer; 2020 Jun; 28(6):2589-2596. PubMed ID: 31529159
[TBL] [Abstract][Full Text] [Related]
2. Do treatment patterns alter beliefs cancer patients hold regarding oral oncolytic agents?
Sikorskii A; Given CW; Given BA; Vachon E; Marshall V; Krauss JC; Banik A; Majumder A
Psychooncology; 2018 Mar; 27(3):1005-1012. PubMed ID: 29232502
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting medication beliefs among patients newly prescribed oral oncolytic agents.
Marshall VK; Given CW; Given BA; Lehto RH; Sikorskii A
J Psychosoc Oncol; 2022; 40(1):62-79. PubMed ID: 33305993
[TBL] [Abstract][Full Text] [Related]
4. The association between patients' perceived continuity of care and beliefs about oral anticancer treatment.
Cohen Castel O; Shadmi E; Keinan-Boker L; Granot T; Karkabi K; Dagan E
Support Care Cancer; 2019 Sep; 27(9):3545-3553. PubMed ID: 30689046
[TBL] [Abstract][Full Text] [Related]
5. Patients' beliefs and preferences regarding doctors' medication recommendations.
Goff SL; Mazor KM; Meterko V; Dodd K; Sabin J
J Gen Intern Med; 2008 Mar; 23(3):236-41. PubMed ID: 18204991
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Medication Beliefs in Patients With Cancer: An Integrative Review.
Marshall VK; Given BA
Oncol Nurs Forum; 2018 Jul; 45(4):508-526. PubMed ID: 29947359
[TBL] [Abstract][Full Text] [Related]
7. Photo elicitation, an approach to better understanding the patient experience with OAAs: pilot study and future implications.
Manojlovich M; Blok A; Wright N; Azhari E; Farris KB; Friese CR; Mackler E; Titler M; Byrnes M
Support Care Cancer; 2023 Oct; 31(12):652. PubMed ID: 37878093
[TBL] [Abstract][Full Text] [Related]
8. Satisfaction With an Interactive Voice Response System and Symptom Management Toolkit Intervention to Improve Adherence in Patients Prescribed an Oral Anticancer Agent.
Marshall VK; Given BA
Oncol Nurs Forum; 2020 Nov; 47(6):637-648. PubMed ID: 33063783
[TBL] [Abstract][Full Text] [Related]
9. Impact of initiating oral anticancer agents for leukemia on adherence to medications for multiple chronic conditions.
Gatwood J; Dashputre A; Rajpurohit A; Gatwood K; Mackler E; Wallace L; Farris K; Rizvi-Toner A; Farley J
J Oncol Pharm Pract; 2024 Mar; 30(2):342-353. PubMed ID: 37113049
[TBL] [Abstract][Full Text] [Related]
10. Medication Adherence Among Adults With Comorbid Chronic Conditions Initiating Oral Anticancer Agent Therapy for Multiple Myeloma.
Gatwood J; Dashputre A; Rajpurohit A; Gatwood K; Mackler E; Wallace L; Farris K; Rizvi-Toner A; Farley J
JCO Oncol Pract; 2022 Sep; 18(9):e1475-e1483. PubMed ID: 35700416
[TBL] [Abstract][Full Text] [Related]
11. The role of the pharmacist in improving medication beliefs and adherence in cancer patients.
Birand N; Boşnak AS; Diker Ö; Abdikarim A; Başgut B
J Oncol Pharm Pract; 2019 Dec; 25(8):1916-1926. PubMed ID: 30786821
[TBL] [Abstract][Full Text] [Related]
12. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness.
Horne R; Weinman J
J Psychosom Res; 1999 Dec; 47(6):555-67. PubMed ID: 10661603
[TBL] [Abstract][Full Text] [Related]
13. Temporary Stoppages and Burden of Treatment in Patients With Cancer.
Vachon E; Given B; Given C; Dunn S
Oncol Nurs Forum; 2019 Sep; 46(5):E135-E144. PubMed ID: 31424460
[TBL] [Abstract][Full Text] [Related]
14. A Concept Analysis of Oral Anticancer Agent Self-management.
Mason M; Harris MR; Greer JA; Jiang Y
Cancer Nurs; 2022 Mar-Apr 01; 45(2):E374-E387. PubMed ID: 33654013
[TBL] [Abstract][Full Text] [Related]
15. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
[TBL] [Abstract][Full Text] [Related]
16. Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents.
Collado-Borrell R; Escudero-Vilaplana V; Ribed A; Jiménez RR; Peinado II; Herranz-Alonso A; Sanjurjo-Sáez M
Am J Health Syst Pharm; 2020 Aug; 77(17):1393-1402. PubMed ID: 32620958
[TBL] [Abstract][Full Text] [Related]
17. Adherence to oral antineoplastic agents in pediatric oncology. A multicenter study.
Farberman D; Valente P; Malpiedi L; Morosi M; Luisella L;
Arch Argent Pediatr; 2021 Feb; 119(1):44-50. PubMed ID: 33458980
[TBL] [Abstract][Full Text] [Related]
18. Outpatient oral anticancer agent utilization and costs in Manitoba from 2003 to 2016: a population-based study.
Leong C; Czaykowski P; Geirnaert M; Katz A; Dragan R; Yogendran M; Raymond C
Can J Public Health; 2021 Jun; 112(3):530-540. PubMed ID: 33471346
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of the feasibility and preliminary efficacy of a texting intervention on medication adherence in adults prescribed oral anti-cancer agents: study protocol.
Spoelstra SL; Given CW; Sikorskii A; Coursaris CK; Majumder A; DeKoekkoek T; Schueller M; Given BA
J Adv Nurs; 2015 Dec; 71(12):2965-76. PubMed ID: 26100719
[TBL] [Abstract][Full Text] [Related]
20. Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study.
Michetti P; Weinman J; Mrowietz U; Smolen J; Peyrin-Biroulet L; Louis E; Schremmer D; Tundia N; Nurwakagari P; Selenko-Gebauer N
Adv Ther; 2017 Jan; 34(1):91-108. PubMed ID: 27854054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
